Ask AI
ProCE Banner Series

Nursing Perspectives on the Impact of Immune Checkpoint Inhibitors in Early Stages of Cancer

Register now for this 1.5-hour interactive live webinar to hear about recent advances and emerging treatment strategies in the use of immune checkpoint inhibitors in the management of patients with early stages of cancer, including optimal approaches to partner with patients in their care and how to foster health equities. After the webinar, view the on-demand webcast and download the associated slideset for use in your clinic.

To Register: Please click the green “Learn More” button below. On the next page, select Register for Virtual Event. Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

  ANCC
Who Should Attend

This educational program is intended for oncology nurses and other healthcare professionals who care for patients with cancer.

All Events

Nursing Perspectives on the Impact of Immune Checkpoint Inhibitors in Early Stages of Cancer

Past Events

May

09

2023

6:30 PM - 8:00 PM Eastern Time (ET)

Virtual

Topics

  • Welcome and Introduction
  • Rationale for the use of immunotherapy in early stages of cancer
  • Benefits of immunotherapy in early stages of cancer
  • Recent approvals and expanded indications for immune checkpoint inhibitors in early stages of cancer
  • Case-based strategies to ensure optimal patient care
  • Partnering with patients in their care
  • Fostering health equities
  • Final Thoughts and Audience Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Program Overview
This program will provide expert perspectives from a medical oncologist and an oncology nurse on the role and benefits of immunotherapy in early stages of cancer, including evidence-based approaches for the personalized care of patients, and optimal strategies to prevent, mitigate and manage immune-related adverse events to achieve maximal treatment outcomes in patients with early stages of cancer.

Goal Statement
The goal of this activity is to improve the knowledge, confidence, and competence of oncology nurses to understand and explain available clinical data on novel and emerging approaches for early stages of cancer and how these data and treatments will affect clinical outcomes, as well as how to promote health equity among patients with cancer. 

Target Audience
This educational program is intended for oncology nurses and other healthcare professionals who care for patients with cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Evaluate key clinical data and current indications for immune checkpoint inhibitor–based neoadjuvant or adjuvant therapy in patients with earlier stages of solid tumor cancers
  • Apply a focused nursing assessment navigating the implications of immuno-oncology in early stages of cancer and knowledge of adverse events unique to immune checkpoint inhibitors
  • Communicate with patients about the expectations of early treatment with ICIs on their overall prognosis, along with the importance of frequent monitoring and early reporting of immune-related adverse events
  • Identify patients most likely to benefit from treatment with immune checkpoint inhibitor therapy or enrollment on clinical trials, considering existing barriers that create racial and socioeconomic disparities in care

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Bristol Myers Squibb.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191